Quest Diagnostics Incorporated (DGX) is listed on NYSE in Healthcare Services Stocks. It is $242.71, -0.78%, with a $26.8B market cap. RSI is 74.9, overbought. The latest reported quarter beat estimates. Insiders were net sellers across the listed trades.
Technical Analysis
RSI (14) 74.9 Overbought
Market Cap $26.8B
Volume 353.1K
Fundamentals — 10-Q Q2 2026
Revenue $5.9B
Net Income $572.0M
EPS $5.08
Gross Margin 33.2%
Operating Margin 14.4%
Net Margin 9.6%
Debt / Equity 0.8x
P/E Ratio 47.8x
Earnings
Recent Insider Trades
| Name | Title | Type | Shares | Price | Value | Date |
|---|---|---|---|---|---|---|
| Delaney Mark E | SVP & Chief Commercial Officer | Sell | 1,600 | $235.18 | $376,288 | 2026 Jul 28 |
| Kuppusamy Karthik | SVP, Clinical Solutions | Sell | 8,147 | $200.00 | $1.6M | 2026 Jun 4 |
| Davis J. E. | CEO and President | Sell | 10,000 | $194.14 | $1.9M | 2026 Jun 1 |
| Doherty Catherine T. | EVP, Regional Businesses | Sell | 5,558 | $206.21 | $1.1M | 2026 Mar 5 |
| Prevoznik Michael E | SVP & General Counsel | Sell | 3,878 | $206.21 | $799,682 | 2026 Mar 5 |
| Plewman Patrick | SVP for Diagnostic Services | Sell | 2,855 | $206.21 | $588,730 | 2026 Mar 5 |
| Kuppusamy Karthik | SVP, Clinical Solutions | Sell | 2,628 | $204.86 | $538,372 | 2026 Mar 4 |
| Doherty Catherine T. | EVP, Regional Businesses | Sell | 632 | $207.73 | $131,285 | 2026 Mar 3 |
| Prevoznik Michael E | SVP & General Counsel | Sell | 526 | $207.73 | $109,266 | 2026 Mar 3 |
| Plewman Patrick | SVP for Diagnostic Services | Sell | 410 | $207.73 | $85,169 | 2026 Mar 3 |
| Davis J. E. | CEO and President | Sell | 10,000 | $212.52 | $2.1M | 2026 Mar 2 |
| Gregg Vicky B | Director | Sell | 1,250 | $191.76 | $239,700 | 2025 Nov 25 |
| Davis J. E. | CEO and President | Sell | 55,093 | $192.22 | $10.6M | 2025 Nov 25 |
| Delaney Mark E | SVP & Chief Commercial Officer | Sell | 7,946 | $187.35 | $1.5M | 2025 Nov 18 |
| Pfeiffer Gary M | Director | Sell | 1,482 | $182.40 | $270,317 | 2025 Oct 22 |
| Prevoznik Michael E | SVP & General Counsel | Sell | 227 | $188.13 | $42,706 | 2025 Sep 26 |
| Prevoznik Michael E | SVP & General Counsel | Sell | 28,463 | $187.12 | $5.3M | 2025 Sep 24 |
| Plewman Patrick | SVP for Diagnostic Services | Sell | 1,975 | $185.00 | $365,375 | 2025 Aug 21 |
| Plewman Patrick | SVP for Diagnostic Services | Sell | 4,532 | $183.00 | $829,356 | 2025 Aug 19 |
| Plewman Patrick | SVP for Diagnostic Services | Sell | 1,975 | $180.00 | $355,500 | 2025 Aug 15 |
Other Healthcare Services Stocks
| Ticker | Price | RSI | Mkt Cap |
|---|---|---|---|
| | $894.35 | 58.3 | $104.3B |
| | $417.60 | 60.5 | $92.6B |
| | $321.94 | 56.1 | $61.4B |
| | $59.10 | 41.6 | $11.7B |
| | $335.24 | 72.2 | $27.2B |
| | $523.25 | 46.4 | $6.8B |
| | $326.17 | 62.5 | $47.0B |
| | $600.45 | 57.5 | $16.8B |
Take DGX further
- Browse Healthcare Services Stocks for the rest of the group, with what the businesses in it have in common and where they differ.
- Put DGX in a portfolio and see what it does to total return, drawdown, and how the rest of your holdings move with it. Compares against the S&P 500 over the same days, free and without an account.
- Screen for others like it by RSI, valuation, market cap, and insider activity.
- Check the earnings calendar for when Quest Diagnostics Incorporated next reports.
Set alerts on DGX
Get notified when Quest Diagnostics Incorporated hits your price targets or technical conditions are met.
Get Started Free